how piramal pharma maintains a successful regulatory track record? | n18v | cnbc tv18
Published 6 months ago • 274 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
1:55
decoding the demerger plan of piramal enterprises | chartbusters | cnbc-tv18
-
2:36
laurus labs, piramal pharma etc in focus after us house of representatives passes the biosecure act
-
4:48
spotlight on us' leading affordable pharma player | know all about amneal pharma | digital
-
10:27
hope to capture 10-20% market share in the electrolysers sapce: thermax | cnbc tv18
-
2:04
piramal pharma share latest news | piramal pharma share news today |piramal pharma share price today
-
11:44
laurus labs will rally like crazy between 2024-2028
-
0:52
focus on piramal pharma: u.s. fda concludes inspection of firm's sellersville manufacturing facility
-
1:25
negen capital's neil bahal shares his views on piramal pharma's stock | trading hour | cnbc-tv18
-
4:06
in the swotlight: all about business segment, financial & more of piramal pharma | inside out
-
8:19
us biosecure act provides a big opportunity to indian pharma industry: biocon & biocon biologics
-
7:52
can get to 22-25% margin on a 3-5 year basis: piramal pharma chairperson nandini piramal | cnbc tv18
-
3:06
nandini piramal on the growth of piramal pharma after listing in oct 2022 | n18v | cnbc tv18
-
1:52
strong sequential recovery spurs piramal pharma | trading hour | cnbc tv18
-
3:16
decoding the highs & lows of pharma stocks in 2022 | business lunch | cnbc-tv18
-
2:29
india's piramal group chairman discusses the investment in its pharma business from carlyle group
-
10:56
how did pharma & real estate sector perform in 2022? | take a look | rewind 2022 | cnbc-tv18
-
1:56
focus on piramal pharma, divis labs & gland pharma: street betting on a qoq recovery? | cnbc-tv18
-
1:15
uniform code of pharma marketing practices to come to effect, sources say | midcap radar | cnbc-tv18
-
0:45
d-street chatter | stocks to watch out, kotak mahindra bank, piramal pharma | n18s | cnbc tv18
-
2:51
decoding key triggers for pharma stocks as it outperform the nifty this week | cnbc-tv18
-
22:24
in depth analysis of navin fluorine & putting swotlight on piramal pharma | inside out | cnbc-tv18
-
1:15
total value of investments stands at ₹3,817 cr: piramal ent's exposure to aif | cnbc tv18